Ambev S.A. $ABEV Shares Purchased by Assetmark Inc.

Assetmark Inc. raised its stake in Ambev S.A. (NYSE:ABEV) by 61.5% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 872,694 shares of the company’s stock after buying an additional 332,425 shares during the quarter. Assetmark Inc.’s holdings in Ambev were worth $2,548,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. GQG Partners LLC raised its stake in shares of Ambev by 9.1% during the fourth quarter. GQG Partners LLC now owns 172,969,655 shares of the company’s stock valued at $427,235,000 after purchasing an additional 14,468,963 shares in the last quarter. Morgan Stanley raised its position in shares of Ambev by 291.2% during the 4th quarter. Morgan Stanley now owns 45,462,628 shares of the company’s stock worth $112,293,000 after buying an additional 33,842,540 shares in the last quarter. Bank of America Corp DE raised its position in shares of Ambev by 9.9% during the 2nd quarter. Bank of America Corp DE now owns 27,505,192 shares of the company’s stock worth $66,288,000 after buying an additional 2,479,310 shares in the last quarter. Brandes Investment Partners LP lifted its stake in shares of Ambev by 4.0% in the 4th quarter. Brandes Investment Partners LP now owns 22,600,124 shares of the company’s stock worth $55,822,000 after acquiring an additional 874,657 shares during the period. Finally, CANADA LIFE ASSURANCE Co boosted its holdings in shares of Ambev by 74.8% in the second quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company’s stock valued at $32,624,000 after acquiring an additional 5,740,155 shares in the last quarter. Institutional investors and hedge funds own 8.13% of the company’s stock.

Analyst Upgrades and Downgrades

ABEV has been the topic of a number of research analyst reports. Scotiabank lowered shares of Ambev from a “sector outperform” rating to a “sector perform” rating in a research note on Wednesday, July 15th. Barclays lifted their price objective on shares of Ambev from $3.00 to $3.50 and gave the stock an “equal weight” rating in a research note on Wednesday, May 6th. Weiss Ratings downgraded shares of Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, May 6th. Wall Street Zen cut Ambev from a “buy” rating to a “hold” rating in a report on Monday, July 13th. Finally, UBS Group increased their price objective on Ambev from $2.65 to $2.90 and gave the company a “sell” rating in a research report on Thursday, May 14th. Six investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus target price of $3.09.

Insider Activity

In related news, insider Paulo Andre Zagman sold 136,250 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was sold at an average price of $3.41, for a total value of $464,612.50. Following the completion of the sale, the insider owned 230,535 shares of the company’s stock, valued at approximately $786,124.35. The trade was a 37.15% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Ambev Stock Performance

Shares of Ambev stock opened at $3.10 on Friday. Ambev S.A. has a 12 month low of $2.10 and a 12 month high of $3.45. The stock has a market cap of $48.78 billion, a PE ratio of 16.29, a price-to-earnings-growth ratio of 1.83 and a beta of 0.64. The company has a quick ratio of 0.78, a current ratio of 1.03 and a debt-to-equity ratio of 0.02. The business has a fifty day simple moving average of $3.14 and a 200-day simple moving average of $3.01.

Ambev (NYSE:ABEV) last released its earnings results on Wednesday, May 6th. The company reported $0.05 earnings per share for the quarter, meeting the consensus estimate of $0.05. Ambev had a return on equity of 16.63% and a net margin of 17.69%.The company had revenue of $4.32 billion for the quarter, compared to analysts’ expectations of $4.38 billion. On average, sell-side analysts anticipate that Ambev S.A. will post 0.2 EPS for the current fiscal year.

Ambev Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 11th. Stockholders of record on Wednesday, June 24th will be paid a dividend of $0.0092 per share. The ex-dividend date of this dividend is Wednesday, June 24th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.2%. Ambev’s dividend payout ratio (DPR) is 10.53%.

Ambev Profile

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.